Skip to main content
Clinical Trials/CTRI/2013/08/003876
CTRI/2013/08/003876
Recruiting
未知

Evaluation of host immune responses and parasite proteome in patients with severe/complicated malaria

Department of Biosciences and Bioengineering Indian Institute of Technology0 sites300 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Severe malaria(P vivax and P falciparum)Non malarial feverHealthy participants
Sponsor
Department of Biosciences and Bioengineering Indian Institute of Technology
Enrollment
300
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Biosciences and Bioengineering Indian Institute of Technology

Eligibility Criteria

Inclusion Criteria

  • Participants of either sex aged 18 to 65 years both inclusive
  • Either gender
  • with a diagnosis of severe/complicated vivax malaria OR with a diagnosis of severe malaria due to mixed infection
  • Confirmed nonmalaria fever patients dengue fever (serum IgM antibody titre) leptospirosis (microscopic agglutination test)and enteric fever (widal test)
  • Healthy volunteers as judged by medical history clinical examination and laboratory investigations
  • Patients or their legally accepted representatives willing to provide written informed consent

Exclusion Criteria

  • Patients with history of significant systematic disease like autoimmune disorders chronic liver diseases psychiatric illness and bleeding disorders etc As judged by history and physical examination
  • Patients with a diagnosis of complications to dengue leptospirosis or any other infectious disease
  • A female patient who is pregnant at enrolling

Outcomes

Primary Outcomes

Not specified

Similar Trials